We're making updates and relaunching soon. Get notified

Straight answers about GLP-1 medications

Plain-language guides on dosing, side effects, costs, and what to look for in a provider.

Relaunching Soon

  • Relaunching as an independent GLP-1 guide
  • Get notified when we relaunch
  • We only ask for your email
Get Started

One email to confirm. Unsubscribe anytime.

Switching from Brand-Name to Compounded Semaglutide or Tirzepatide

Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Compounded semaglutide and tirzepatide are not the same as brand-name products such as Wegovy or Zepbound and may differ in formulation, purity, and potency.

You are on a brand-name GLP-1 and it is working well enough, but the cash price is hard to keep paying month after month. You have probably seen that compounded programs often cost less and you want to know what it would actually take to move. Here is what switching from a brand-name product to a compounded medication containing the same drug substance involves, who decides your dose, and what you need to know before you make the move.

This page is about switching from a brand-name GLP-1 to a compounded one. If instead you are thinking about changing from one molecule to another, semaglutide to tirzepatide or the reverse, that is a different decision and we cover it separately in our guide to switching between semaglutide and tirzepatide.

Why people switch to compounded

For most people, the answer is cost. Paid out of pocket, brand-name GLP-1 medications can be expensive, and insurance coverage for weight management is inconsistent. Many plans exclude it entirely. Even when a plan covers it, prior authorization can take time.

Compounded semaglutide or tirzepatide is usually offered by cash-pay telehealth programs and often costs less than brand-name medication paid out of pocket. It is prepared by a compounding pharmacy rather than manufactured by the drug’s maker under an FDA-approved application. That different production model is why the price is often lower. It is not a sign of clinical equivalence. A compounded medication is not FDA-approved and is not the same product as a brand-name one.

Cost is the main reason people look at compounded options, but price is only one part of the decision. FDA status, how your dose is handled, and how stable access is all matter too. You can read more about compounded medications and how they fit into the wider picture on our hub page.

What switching actually involves

This is the part that surprises people most. You do not transfer your prescription, and you do not simply move your refills to a new pharmacy. Switching to a compounded program usually means starting fresh with a new provider evaluation and a new prescription.

That is not a hurdle so much as how it has to work. A compounded GLP-1 is a different product, prepared a different way, so a licensed provider at the program you choose has to review your health history, look at the medication and dose you are on now, and decide whether a compounded medication is appropriate for you. That provider makes the call, and a provider may decide it is not right for you.

At most telehealth programs, the process looks like this.

Step 1: Health history

You fill out a form covering your health history, your current GLP-1 and dose, and your goals. List exactly what you take now, including the dose and when you last took it, so the provider has the full picture.

Step 2: Provider review

A licensed provider reviews your information, including your current medication, and decides whether a compounded GLP-1 is clinically appropriate and how to approach your dose.

Step 3: Pharmacy preparation

If a provider prescribes it, a state-licensed compounding pharmacy prepares the medication. Ask which pharmacy the program uses.

Step 4: Delivery and follow-up

The medication usually arrives by mail with supplies for injection. A proper program includes follow-up with a licensed provider during the transition, so you are not left to figure it out alone.

Transformation Health does not accept payment from providers. How we make money.

Will your dose change?

Maybe. This is a decision your prescriber makes, not one you make on your own or one that happens automatically.

The prescriber reviews where you are in your current regimen, how long you have been on it, and how you have responded, then decides how to proceed. One practical difference matters here. Brand-name products come in set presentations labeled in milligrams, such as prefilled pens (and, for Zepbound, vials)[1][2]. Compounded medication is often supplied in vials that you draw up with a syringe, and the dose may be written in milliliters or syringe units. Because the formats differ, there is no conversion chart you can rely on in place of your prescriber’s instructions. Do not assume the numbers carry over.

Measuring matters. The FDA has received reports of adverse events, some requiring hospitalization, that may be related to dosing errors with compounded injectable semaglutide, including people measuring and injecting the wrong amount[3]. The FDA encourages patients to talk with their provider or compounder about how to measure and give the intended dose[3]. The brand-name labels make a similar point: when the presentation a person uses changes, they should be trained on the new one[1][2].

Timing can matter too. The Wegovy label says that if two or more weekly doses in a row are missed, dosing should restart at a lower dose to reduce the risk of gastrointestinal side effects[2]. A gap during a switch is one more reason to plan the timing with your prescribers rather than on your own.

The most important thing during a switch is simple. Do not adjust your dose on your own, and do not try to match your old regimen by guesswork. Follow the plan your prescriber gives you. If anything about it is unclear, ask before you start.

What to know before you switch

Moving to a compounded program can make sense for some people, but go in with clear eyes. A few things matter.

Compounded is not the same as brand-name. Compounded medications are not FDA-approved, and the FDA does not review them for safety, effectiveness, or quality before they are marketed[4]. A compounded medication contains semaglutide or tirzepatide, but it is not the same product as the brand-name medication you take now. Formulation, potency, and purity may differ, so you cannot assume it will perform the same way. If you want to understand quality oversight and what to look for, our page on the safety of compounded semaglutide goes deeper.

Do not stop your current medication on your own. Talk with your current prescriber before you change anything. They can advise you on timing so you avoid an unintended gap or overlap. Any change to your treatment should be a clinical decision.

Availability has changed and can change again. Compounding of these drugs depends on FDA drug shortage status and on state and federal pharmacy law. On December 19, 2024, the FDA reissued its determination that the tirzepatide injection shortage was resolved; after a March 5, 2025 court decision, the FDA said its enforcement discretion period for state-licensed 503A pharmacies had ended, and for 503B outsourcing facilities it ran until March 19, 2025[5]. On February 21, 2025, the FDA determined the semaglutide injection shortage was resolved; the FDA said its 503A period ended after an April 24, 2025 court decision (the original end date was April 22, 2025), and its 503B period ended May 22, 2025[5]. The FDA page has later updates, most recently dated April 1, 2026; check it for the current statement[5]. If you are planning longer-term treatment, ask the provider you choose what would happen if the compounded option became unavailable.

Side effects still apply. The brand-name labels for semaglutide (Wegovy) and tirzepatide (Zepbound) list nausea, diarrhea, vomiting, constipation, and abdominal pain among the most common side effects, and both carry a boxed warning about thyroid C-cell tumors[1][2]. They say not to use the medication if you or a family member has had medullary thyroid carcinoma or if you have Multiple Endocrine Neoplasia syndrome type 2[1][2]. Compounded versions have not been evaluated by the FDA, so label information describes the brand-name products studied.

Results are individual. Switching does not guarantee you keep the same results. Individual results vary, and weight loss is not guaranteed. The provider you choose can help you set realistic expectations for your situation.

If you want a fuller picture of how programs decide who is a candidate, see our GLP-1 eligibility guide.

What it costs

This is usually the whole reason for the switch, so here is the straightforward version. Transformation Health does not sell medication or set prices. Prices vary by program and dose. We plan to publish current market prices with sources and capture dates; until then, use these factors to compare what programs quote you.

  • What the fee includes. Some monthly fees bundle medication, provider visits, and follow-up. Others cover the medication only.
  • Dose tier. Many programs charge more at higher doses, so a starting-dose price may not be what you pay at the dose you are on now. If you are switching at a higher dose, ask for the price at that dose.
  • Lab work. Some programs include required labs; others bill them separately or ask you to get them through your own provider.
  • Shipping and supplies. Check whether shipping, syringes, alcohol pads, and sharps containers are included.
  • Add-on fees and cancellation terms. Look for membership or consultation fees, minimum commitments, prepay requirements, and how cancellation works.

Compare the total cost: medication at your likely dose, dose increases, visits, labs, shipping, membership fees, and cancellation terms. Then compare that total with what you pay now, including any manufacturer self-pay program or insurance coverage you might qualify for.

Form matters too. FDA-approved tirzepatide is available as an injection only[1]. Wegovy is FDA-approved as an injection and as a tablet[2]. Any oral tirzepatide a program offers is compounded and not FDA-approved, and compounded oral semaglutide is not FDA-approved either. For a closer look at what a compounded semaglutide fee may cover, see compounded semaglutide cost.

Transformation Health does not accept payment from providers. How we make money.

How to start

Start with the prescriber you have now. Tell them you are considering a compounded program and ask how to time a switch, what dose you are on in milligrams, and what to watch for. Then compare programs on total cost, on which pharmacy prepares the medication, and on whether a licensed provider follows up with you during the transition. If you would rather see the full walkthrough first, our guide on how to get compounded semaglutide covers each step.

Programs set their own criteria for who is a candidate, and a licensed provider at the program decides whether a prescription is appropriate. Being on a brand-name GLP-1 now does not mean a new provider will prescribe a compounded one.

We're relaunching soon

We're relaunching as an independent GLP-1 guide. Leave your email and we'll let you know when your free custom report is ready.

Get Started

Important disclosures

This content is for general education and is not medical advice. Talk with a licensed provider about your situation.

Compounded GLP-1 medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed[4]. Compounded semaglutide and tirzepatide are not the same as brand-name products such as Wegovy or Zepbound, which went through FDA review, and they may differ in formulation, purity, and potency. You cannot assume the two will produce the same results.

Do not start, stop, or change any prescription medication on your own. Switching from a brand-name GLP-1 to a compounded one requires a new evaluation and prescription from a licensed provider. Dose decisions are made by the prescriber based on your history and current regimen, not by you.

Results vary. Weight loss is not guaranteed and depends on many factors, including your starting weight, age, metabolism, adherence, eating habits, activity, sleep, and overall health. Availability of compounded GLP-1 medications depends on FDA policy and applicable state and federal pharmacy compounding laws, which may change[5].

Citations

[1] U.S. Food and Drug Administration. ZEPBOUND (tirzepatide) injection, prescribing information, Boxed Warning and sections 2.4, 3, 4, and 6. Revised 08/2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806Orig1s041correctedlbl.pdf

[2] U.S. Food and Drug Administration. WEGOVY (semaglutide) injection and tablets, prescribing information, Boxed Warning and sections 1, 2.1, 2.4, 4, and 6. Revised 06/2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215256s025lbl.pdf

[3] U.S. Food and Drug Administration. “FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss,” section “Dosing concerns with compounded semaglutide and tirzepatide.” Content current as of 10/01/2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss (Accessed 2026-10-16.)

[4] U.S. Food and Drug Administration. “FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.” Content current as of 10/01/2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss (Accessed 2026-10-16.)

[5] U.S. Food and Drug Administration. “FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize.” Content current as of 04/01/2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize (Accessed 2026-10-16.)

Important: This content is for general education and is not medical advice. Talk with a licensed provider about your situation. Transformation Health is an independent GLP-1 guide. It does not provide medical care, prescribe, compound, or sell medication. A licensed provider decides whether a prescription is appropriate. Compounded semaglutide and tirzepatide are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality. Compounded semaglutide and tirzepatide are not the same as brand-name products such as Wegovy or Zepbound and may differ in formulation, purity, and potency. Results vary. Availability of compounded GLP-1 medications depends on FDA policy and applicable state and federal pharmacy compounding laws, which may change. Wegovy is a trademark of Novo Nordisk A/S. Zepbound is a trademark of Eli Lilly and Company. Transformation Health is not affiliated with or endorsed by these companies. Transformation Health does not accept payment from providers. How we make money.

FAQ

Frequently Asked Questions

Everything you need to know about getting started.

Still have questions?

Contact our support team
Can I switch from a brand-name GLP-1 to a compounded one?
Some people do, usually to lower their monthly cost. You do not transfer or refill an existing prescription, though. Switching usually means a new evaluation and a new prescription from a licensed provider at the program you choose. That provider reviews your health history, your current medication and dose, and your goals, then decides whether a compounded GLP-1 is appropriate for you. A provider may decide it is not.
Will I have to change my dose when I switch?
Possibly, and that is a decision for your prescriber, not something to work out yourself. Compounded medication is often supplied in vials that you draw up with a syringe, and the dose may be written in milliliters or syringe units rather than milligrams. Do not use a conversion chart or assume your dose carries over one to one. Follow the instructions the prescriber and pharmacy give you, and ask them to show you how to measure your dose.
Is compounded as good as what I am on now?
You cannot assume it is the same. A compounded GLP-1 contains semaglutide or tirzepatide, but it is not the same product as a brand-name medication such as Wegovy or Zepbound. Compounded medications are not FDA-approved, and the FDA does not review them for safety, effectiveness, or quality. Formulation, potency, and purity may differ. A licensed provider can explain the tradeoffs and decide whether it is appropriate for you.
Should I stop my current medication on my own before I switch?
No. Do not stop, pause, or change your current medication on your own. Talk with your current prescriber first. They can advise you on timing so there is no unplanned gap or overlap. Any change to your treatment should be a clinical decision, not something you do while you wait for a new program to start.
What does a compounded GLP-1 program cost?
Prices vary by program and dose. Some programs charge one monthly fee that bundles medication, provider visits, and labs; others charge for the medication only and bill visits, labs, or a membership separately. Compare the total cost, including medication at your likely dose, dose increases, provider visits, labs, shipping, membership fees, and cancellation terms.

We're relaunching soon

We're relaunching as an independent GLP-1 guide. Leave your email and we'll let you know when your free custom report is ready.

Get Started

About This Site: Disclosures

Who We Are

transformationhealth.com is a website operated by Amerigo Health LLC. Transformation Health is an independent publisher. It does not provide medical care, prescribe, or sell medication, and does not give medical advice. Providers and programs mentioned on this site are independent third parties.

How We Make Money

Transformation Health does not accept payment from providers.

Educational Purpose

This content is for general education and is not medical advice. Talk with a licensed provider about your situation. Results vary. Trial results describe study participants and are not a prediction for any individual.

Compounded Medications

Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Compounded semaglutide and tirzepatide are not the same as brand-name products such as Wegovy, Ozempic, Zepbound, or Mounjaro. They may differ in formulation, purity, and potency.

Trademarks

Wegovy and Ozempic are trademarks of Novo Nordisk A/S. Zepbound and Mounjaro are trademarks of Eli Lilly and Company. Transformation Health is not affiliated with or endorsed by these companies.